Separation and detection of rare cells in a microfluidic disk via negative selection

被引:62
作者
Chen, Chen-Lin [1 ]
Chen, Ken-Chao [1 ]
Pan, Yu-Cheng [1 ]
Lee, Tai-Ping [2 ]
Hsiung, Lo-Chang [1 ]
Lin, Cheng-Ming [1 ]
Chen, Chang-Yu [1 ]
Lin, Ching-Hung [3 ]
Chiang, Bor-Luen [4 ]
Wo, Andrew M. [1 ]
机构
[1] Natl Taiwan Univ, Inst Appl Mech, Taipei, Taiwan
[2] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan
[3] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Oncol, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Med Res, Taipei 10764, Taiwan
关键词
CIRCULATING TUMOR-CELLS; METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; MATERNAL BLOOD; FETAL CELLS; PRENATAL-DIAGNOSIS; EPITHELIAL-CELLS; COMPACT DISC; WHOLE-BLOOD; LABEL-FREE;
D O I
10.1039/c0lc00332h
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cyto-analysis of rare cells often requires separation and detection with each procedure posing substantial challenges. This paper presents a disk-based microfluidic platform for both procedures via an immunomagnetic negative selection process. The microfluidic platform's unique features include a multistage magnetic gradient to trap labeled cells in double trapping areas, drainage of fluid to substantially shorten detection time, and a bin-like regions to capture target cells to facilitate a seamless enumeration process. Proof-of-concept was conducted using MCF7 as target rare cells (stained with anti-cytokeratin-FITC antibodies) spiked into Jurkat Clone E6-1 non-target cells (labeled with anti-CD45-PE and anti-PE BD magnetic beads). Then, mononuclear cells (MNC) from healthy blood donors were mixed with MCF7s, modeling rare cells, and tested in the disk. Results show a non-linear magnetic coupling effect of the multistage magnet substantially increased the trapping efficacy over that of a single magnet, contributing to the depletion rate of Jurkats, which reaches 99.96%. Detection time is extensively shortened by depletion of 95% of non-cell-containing fluid in the collection area. The average yield of detected MCF7 cells is near-constant 60 +/- 10% over a wide range of rarity from 10(-3) to 10(-6) and this yield also holds for the MCF7/MNC complex mixture. Comparison with autoMACS and BD IMagnet separators revealed the average yield from the disk (60%) is superior to that of autoMACS (37.3%) and BD IMagnet (48.3%). The advantages of near-constant yield, roughly 30 min of operation, an acceptable level of cell loss, and potentially low cost system should aid in cyto-analysis of rare cells.
引用
收藏
页码:474 / 483
页数:10
相关论文
共 48 条
[1]   Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor [J].
Adams, Andre A. ;
Okagbare, Paul I. ;
Feng, Juan ;
Hupert, Matuesz L. ;
Patterson, Don ;
Goettert, Jost ;
McCarley, Robin L. ;
Nikitopoulos, Dimitris ;
Murphy, Michael C. ;
Soper, Steven A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (27) :8633-8641
[2]  
ALIXPANABIERES C, 2010, AM ASS CANC RES 101, P179
[3]   Parallel nanoliter microfluidic analysis system [J].
Andersson, Per ;
Jesson, Gerald ;
Kylberg, Gunnar ;
Ekstrand, Gunnar ;
Thorsen, Gunnar .
ANALYTICAL CHEMISTRY, 2007, 79 (11) :4022-4030
[4]   Sharpening the Tools: A summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis [J].
Bianchi, DW ;
Hanson, J .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2006, 19 (04) :199-207
[5]   Circulating tumor cells in metastatic breast cancer - Toward individualized treatment? [J].
Braun, S ;
Marth, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :824-826
[6]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[7]   Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients [J].
Deng, Glenn ;
Herrler, Michael ;
Burgess, David ;
Manna, Edward ;
Krag, David ;
Burke, Julian F. .
BREAST CANCER RESEARCH, 2008, 10 (04)
[8]   Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells [J].
Fehm, T ;
Solomayer, EF ;
Meng, S ;
Tucker, T ;
Lane, N ;
Wang, J ;
Gebauer, G .
CYTOTHERAPY, 2005, 7 (02) :171-185
[9]   Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody [J].
Gleghorn, Jason P. ;
Pratt, Erica D. ;
Denning, Denise ;
Liu, He ;
Bander, Neil H. ;
Tagawa, Scott T. ;
Nanus, David M. ;
Giannakakou, Paraskevi A. ;
Kirby, Brian J. .
LAB ON A CHIP, 2010, 10 (01) :27-29
[10]   Centrifugal microfluidics for biomedical applications [J].
Gorkin, Robert ;
Park, Jiwoon ;
Siegrist, Jonathan ;
Amasia, Mary ;
Lee, Beom Seok ;
Park, Jong-Myeon ;
Kim, Jintae ;
Kim, Hanshin ;
Madou, Marc ;
Cho, Yoon-Kyoung .
LAB ON A CHIP, 2010, 10 (14) :1758-1773